ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/02/06 | 3,300 | 3,435 | 3,295 | 3,435 | +160 | +4.9% | 666,100 |
| 2025/02/05 | 3,230 | 3,280 | 3,195 | 3,275 | +35 | +1.1% | 376,200 |
| 2025/02/04 | 3,220 | 3,250 | 3,190 | 3,240 | +35 | +1.1% | 307,700 |
| 2025/02/03 | 3,235 | 3,245 | 3,150 | 3,205 | -145 | -4.3% | 497,800 |
| 2025/01/31 | 3,335 | 3,355 | 3,280 | 3,350 | +30 | +0.9% | 481,500 |
| 2025/01/30 | 3,330 | 3,430 | 3,320 | 3,320 | -5 | -0.2% | 673,100 |
| 2025/01/29 | 3,255 | 3,325 | 3,220 | 3,325 | +70 | +2.2% | 462,700 |
| 2025/01/28 | 3,150 | 3,280 | 3,120 | 3,255 | +70 | +2.2% | 567,400 |
| 2025/01/27 | 3,200 | 3,255 | 3,155 | 3,185 | +10 | +0.3% | 581,400 |
| 2025/01/24 | 3,075 | 3,185 | 3,065 | 3,175 | +50 | +1.6% | 486,800 |
| 2025/01/23 | 3,030 | 3,130 | 2,981 | 3,125 | +80 | +2.6% | 805,100 |
| 2025/01/22 | 3,105 | 3,120 | 3,000 | 3,045 | -75 | -2.4% | 696,900 |
| 2025/01/21 | 3,125 | 3,180 | 3,105 | 3,120 | +45 | +1.5% | 426,700 |
| 2025/01/20 | 3,115 | 3,130 | 3,045 | 3,075 | -40 | -1.3% | 392,400 |
| 2025/01/17 | 3,155 | 3,165 | 3,090 | 3,115 | -60 | -1.9% | 422,500 |
| 2025/01/16 | 3,170 | 3,260 | 3,145 | 3,175 | +20 | +0.6% | 614,700 |
| 2025/01/15 | 3,105 | 3,180 | 3,090 | 3,155 | +30 | +1% | 522,500 |
| 2025/01/14 | 3,075 | 3,225 | 3,035 | 3,125 | +40 | +1.3% | 859,200 |
| 2025/01/10 | 3,100 | 3,100 | 3,045 | 3,085 | -10 | -0.3% | 317,100 |
| 2025/01/09 | 3,055 | 3,150 | 3,015 | 3,095 | -10 | -0.3% | 636,700 |
| 2025/01/08 | 3,065 | 3,110 | 3,035 | 3,105 | +50 | +1.6% | 492,200 |
| 2025/01/07 | 3,090 | 3,180 | 3,040 | 3,055 | -35 | -1.1% | 1,285,100 |
| 2025/01/06 | 3,360 | 3,370 | 3,090 | 3,090 | -315 | -9.3% | 1,777,700 |
| 2024/12/30 | 3,560 | 3,595 | 3,400 | 3,405 | -205 | -5.7% | 1,343,000 |
| 2024/12/27 | 3,420 | 3,680 | 3,420 | 3,610 | +270 | +8.1% | 2,152,900 |
| 2024/12/26 | 3,345 | 3,370 | 3,300 | 3,340 | ±0 | ±0% | 922,600 |
| 2024/12/25 | 3,400 | 3,425 | 3,315 | 3,340 | -95 | -2.8% | 993,800 |
| 2024/12/24 | 3,345 | 3,435 | 3,330 | 3,435 | +55 | +1.6% | 906,300 |
| 2024/12/23 | 3,355 | 3,450 | 3,310 | 3,380 | +165 | +5.1% | 1,349,000 |
| 2024/12/20 | 3,445 | 3,450 | 3,200 | 3,215 | -250 | -7.2% | 1,566,400 |
| 2024/12/19 | 3,300 | 3,480 | 3,295 | 3,465 | +85 | +2.5% | 1,067,100 |
| 2024/12/18 | 3,175 | 3,450 | 3,170 | 3,380 | +245 | +7.8% | 1,553,700 |
| 2024/12/17 | 3,060 | 3,160 | 3,010 | 3,135 | +80 | +2.6% | 654,900 |
| 2024/12/16 | 3,040 | 3,060 | 2,985 | 3,055 | +15 | +0.5% | 531,100 |
| 2024/12/13 | 3,150 | 3,185 | 3,000 | 3,040 | -70 | -2.3% | 1,028,600 |
| 2024/12/12 | 3,180 | 3,245 | 3,105 | 3,110 | -35 | -1.1% | 872,900 |
| 2024/12/11 | 3,205 | 3,220 | 3,100 | 3,145 | -75 | -2.3% | 531,400 |
| 2024/12/10 | 3,245 | 3,250 | 3,150 | 3,220 | -35 | -1.1% | 723,500 |
| 2024/12/09 | 3,310 | 3,355 | 3,255 | 3,255 | ±0 | ±0% | 618,100 |
| 2024/12/06 | 3,295 | 3,370 | 3,240 | 3,255 | -30 | -0.9% | 509,700 |
| 2024/12/05 | 3,255 | 3,360 | 3,255 | 3,285 | -15 | -0.5% | 639,600 |
| 2024/12/04 | 3,365 | 3,375 | 3,260 | 3,300 | -125 | -3.6% | 1,059,100 |
| 2024/12/03 | 3,270 | 3,475 | 3,215 | 3,425 | +105 | +3.2% | 1,719,100 |
| 2024/12/02 | 3,310 | 3,395 | 3,275 | 3,320 | +20 | +0.6% | 1,393,800 |
| 2024/11/29 | 3,025 | 3,300 | 3,005 | 3,300 | +230 | +7.5% | 1,555,100 |
| 2024/11/28 | 2,964 | 3,115 | 2,954 | 3,070 | +117 | +4% | 1,150,200 |
| 2024/11/27 | 2,822 | 2,968 | 2,796 | 2,953 | +145 | +5.2% | 1,506,000 |
| 2024/11/26 | 2,803 | 2,848 | 2,748 | 2,808 | +10 | +0.4% | 854,600 |
| 2024/11/25 | 2,843 | 2,884 | 2,798 | 2,798 | -16 | -0.6% | 862,300 |
| 2024/11/22 | 2,831 | 2,862 | 2,791 | 2,814 | -36 | -1.3% | 656,600 |
151～
200
件表示中 / 3785件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 249,900円 | +21.7% | +999.9% | 0.00% | 11.51倍 | 3.94倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 科研薬 | 385,000円 | -6.4% | -71.8% | 4.94% | 42.88倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 292,000円 | +7.9% | -3.3% | 2.74% | 8.12倍 | 0.84倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 持田薬 | 320,500円 | +5.1% | -7.0% | 2.50% | 21.04倍 | 0.87倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 209,900円 | +3.1% | -6.5% | 2.29% | 9.74倍 | 1.03倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
